课题基金 / 基金详情

Polymerizations using renewable materials and sustainable practices

Polymerizations using renewable materials and sustainable practices
使用可再生材料和可持续实践的聚合
批准号:
183755-2009
负责人:
Dubé, Marc
金额:
$2.91万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-01-01 至 2010-12-31

项目摘要

项目成果

Dubé, Marc的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many polymerization processes result in negative environmental consequences due to the source of the feedstock (e.g., monomer from petrochemical processes), or due to the emission of volatile organic compounds (VOCs). A number of "greener" pathways to the production of high quality polymeric materials can be envisaged. We will produce environmentally friendly pressure-sensitive adhesives (PSAs) while exploiting two of these pathways: 1) using renewable materials as polymer feedstock; and 2) using safer, low VOC solvents during production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sustainable Polymer Reaction Engineering
  • 批准号:
    RGPIN-2019-03946
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2022
  • 负责人:
    Dubé, Marc
  • 依托单位:
Sustainable Polymer Reaction Engineering
  • 批准号:
    RGPIN-2019-03946
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2021
  • 负责人:
    Dubé, Marc
  • 依托单位:
Enhancing Latex-based Coatings and Pressure Sensitive Adhesives with Carboxylated Cellulose Nanocrystals
  • 批准号:
    560215-2020
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $5.1万
  • 财政年份:
    2021
  • 负责人:
    Dubé, Marc
  • 依托单位:
Sustainable Polymer Reaction Engineering
  • 批准号:
    RGPIN-2019-03946
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2020
  • 负责人:
    Dubé, Marc
  • 依托单位:
国内基金
海外基金
Capture and Release of Droplets Using Advanced Materials for High Technology Applications
  • 批准号:
    52073127
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    Alidad Amirfazli
  • 依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data